{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anticancer activity", "chalcone", "indole", "naphthalene", "tubulin"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30982797", "DateCompleted": {"Year": "2019", "Month": "07", "Day": "29"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "04", "Day": "13"}], "Language": ["eng"], "ELocationID": ["10.1248/cpb.c19-00217"], "Journal": {"ISSN": "1347-5223", "JournalIssue": {"Volume": "67", "Issue": "7", "PubDate": {"Year": "2019", "Month": "Jul", "Day": "01"}}, "Title": "Chemical & pharmaceutical bulletin", "ISOAbbreviation": "Chem Pharm Bull (Tokyo)"}, "ArticleTitle": "Synthesis, Anticancer Activity and Molecular Modeling Studies of Novel Chalcone Derivatives Containing Indole and Naphthalene Moieties as Tubulin Polymerization Inhibitors.", "Pagination": {"StartPage": "725", "EndPage": "728", "MedlinePgn": "725-728"}, "Abstract": {"AbstractText": ["Eighteen novel chalcone derivatives containing indole and naphthalene moieties (2-19) were synthesized and characterized by <sup>1</sup>H-NMR, <sup>13</sup>C-NMR and high resolution (HR)-MS spectra. All compounds were evaluated for their in vitro cytotoxic potential against human hepatocellular carcinoma (HepG2), human colon carcinoma (HCT116) and human breast adenocarcinoma (MCF-7) cell lines. Among them, compound 2, 3, 4 and 7 showed potent activities against tested cancer cell lines. More significantly, compound 7 exhibited the most potent cytotoxic activity against HepG2, HCT116 and MCF-7 with IC<sub>50</sub> values of 0.65, 1.13 and 0.82\u2009\u00b5M, respectively. Furthermore, flow cytometry analysis indicated that compound 7 arrested cancer cells in G2/M phase. The compound 7 also displayed significant inhibition of tubulin polymerization (IC<sub>50</sub>\u2009=\u20093.9\u2009\u00b5M). Finally, molecular docking studies were performed to explore the possible interactions between compound 7 and tubulin binding pockets."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University."}, {"Identifier": [], "Affiliation": "College of Chemistry and Chemical Engineering, Jishou University."}], "LastName": "Wang", "ForeName": "Guangcheng", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University."}, {"Identifier": [], "Affiliation": "College of Chemistry and Chemical Engineering, Jishou University."}], "LastName": "Peng", "ForeName": "Zhiyun", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University."}], "LastName": "Li", "ForeName": "Yongjun", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Chem Pharm Bull (Tokyo)", "NlmUniqueID": "0377775", "ISSNLinking": "0009-2363"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Chalcones"}, {"RegistryNumber": "0", "NameOfSubstance": "Indoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Naphthalenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin Modulators"}, {"RegistryNumber": "2166IN72UN", "NameOfSubstance": "naphthalene"}, {"RegistryNumber": "8724FJW4M5", "NameOfSubstance": "indole"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "metabolism", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["chemistry", "metabolism", "pharmacology"], "DescriptorName": "Chalcones"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "G2 Phase Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Indoles"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["drug effects"], "DescriptorName": "M Phase Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Naphthalenes"}, {"QualifierName": [], "DescriptorName": "Protein Structure, Tertiary"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Tubulin"}, {"QualifierName": ["chemical synthesis", "metabolism", "pharmacology"], "DescriptorName": "Tubulin Modulators"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2019", "Month": "4", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "16", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30982797", "10.1248/cpb.c19-00217"]}}]}